CytoReason vs Springya
CytoReason vs Springya, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Springya on 28/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 28/100
- headcount: 116 against 3
Springya
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CytoReason | Springya |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Digital venture developing an AI-powered instant synergy platform for global healthcare. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, HealthTech, AI-Driven Drug Discovery, Clinical Trials |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2018 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CytoReason | Springya |
|---|---|---|
| Employees | 116 | 3 |
| Headcount growthLast 12 months | +13.7% | Not published |
| Total funding | $128M | Not published |
| Latest round | Series B | Bootstrapped |
| LinkedIn followers | 12,830 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Springya |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 28/100 |
| Traction | 60/100 | 6/100 |
| Team | 70/100 | Not published |
| Search visibility | 30/100 | 15/100 |
| Quality | 78/100 | 42/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 40/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Springya |
|---|---|---|
| CMS | Not detected | Wix |
| Frameworks | Not detected | Jquery |
| Analytics | Segment | Not detected |
CytoReason vs Springya: common questions
Which is better, CytoReason or Springya?
On our 0-100 score CytoReason rates higher (68/100 against 28/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do CytoReason and Springya compare on the numbers?
CytoReason leads on our overall score (68/100 against 28/100), headcount (116 against 3).
Read the full CytoReason review and pricing or the Springya review and pricing. You can also browse other CytoReason alternatives we track.